TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES
Open Access
- 14 September 2016
- journal article
- research article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 32 (3) , 160-166
Abstract
Objectives:Treatment switching refers to the situation in a randomized controlled trial where patients switch from their randomly assigned treatment onto an alternative. Often, switching is from the control group onto the experimental treatment. In this instance, a standard intention-to-treat analysis does not identify the true comparative effectiveness of the treatments under investigation. We aim to describe statistical methods for adjusting for treatment switching in a comprehensible way for nonstatisticians, and to summarize views on these methods expressed by stakeholders at the 2014 Adelaide International Workshop on Treatment Switching in Clinical Trials.Methods:We describe three statistical methods used to adjust for treatment switching: marginal structural models, two-stage adjustment, and rank preserving structural failure time models. We draw upon discussion heard at the Adelaide International Workshop to explore the views of stakeholders on the acceptability of these methods.Results:Stakeholders noted that adjustment methods are based on assumptions, the validity of which may often be questionable. There was disagreement on the acceptability of adjustment methods, but consensus that when these are used, they should be justified rigorously. The utility of adjustment methods depends upon the decision being made and the processes used by the decision-maker.Conclusions:Treatment switching makes estimating the true comparative effect of a new treatment challenging. However, many decision-makers have reservations with adjustment methods. These, and how they affect the utility of adjustment methods, require further exploration. Further technical work is required to develop adjustment methods to meet real world needs, to enhance their acceptability to decision-makers.Keywords
This publication has 19 references indexed in Scilit:
- Adjusting for treatment switching in randomised controlled trials – A simulation study and a simplified two-stage methodStatistical Methods in Medical Research, 2014
- Analyzing Overall Survival in Randomized Controlled Trials with Crossover and Implications for Economic EvaluationValue in Health, 2014
- Methods for Adjusting for Bias Due to Crossover in Oncology TrialsPharmacoEconomics, 2014
- Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation ContextMedical Decision Making, 2014
- Limitation of Inverse Probability-of-Censoring Weights in Estimating Survival in the Presence of Strong Selection BiasAmerican Journal of Epidemiology, 2011
- Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation studyBMC Medical Research Methodology, 2011
- Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized TreatmentsJournal of the American Statistical Association, 2001
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank TestsBiometrics, 2000
- Randomization-based methods for correcting for treatment changes: examples from the Concorde trialStatistics in Medicine, 1999
- Analysis of clinical trials by treatment actually received: Is it really an option?Statistics in Medicine, 1991